Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05076110 · ClinicalTrials.gov registry record · Phase 4

Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures

A Phase 4 study of Hip Arthroscopy, sponsored by Mayo Clinic.

Recruiting
Registry status
Phase 4
Development phase
188
Enrollment target
1
Study location

NCT05076110 is a Phase 4 study of Hip Arthroscopy that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 188 participants, below the 1,108-participant average among 10 other Hip Arthroscopy trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05076110, a Phase 4 study of Hip Arthroscopy, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
Phase 4
Development phase
188 participants
Enrollment target
1
Study location

Study Summary

This study is being conducted to evaluate the effectiveness of post-operative pain control without using narcotic pain medications.

Conditions Studied

Interventions

  • DRUG Acetaminophen
  • DRUG Ibuprofen
  • DRUG Oxycodone
  • DRUG Gabapentin
  • DRUG Methocarbamol

Study Locations (1)

Minnesota

  • Mayo clinic - Rochester

Trial Details

FieldValue
Enrollment Target 188 participants
Start Date 2022-04-07
Est. Completion 2026-04
Phase Phase 4

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT05076110

The ClinicalTrials.gov registry entry for NCT05076110 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 188 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,108-participant average among 10 other Hip Arthroscopy trials with a reported enrollment target (83% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hip Arthroscopy appearing as the primary indexed condition, and to 5 interventions - of which Acetaminophen is the first listed.

NCT05076110 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05076110 about?

NCT05076110 is a clinical study titled "Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures". This study is being conducted to evaluate the effectiveness of post-operative pain control without using narcotic pain medications.

What is the current status of trial NCT05076110?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 188 participants. The study started on 2022-04-07. Estimated completion is 2026-04.

What conditions does trial NCT05076110 study?

This clinical trial studies the following conditions: Hip Arthroscopy.

What interventions are being tested in trial NCT05076110?

The interventions under investigation include: Acetaminophen (DRUG), Ibuprofen (DRUG), Oxycodone (DRUG), Gabapentin (DRUG), Methocarbamol (DRUG).

Who is sponsoring clinical trial NCT05076110?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05076110 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hip Arthroscopy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.